Over the last decade, growing scientific evidence has demonstrated that exercise is an effective therapeutic strategy for type 2 diabetes (112). According to position statements published by the American Diabetes Association, American College of Sports Medicine, and American Heart Association, exercise therapy should be part of a structured lifestyle intervention and include both aerobic and resistance training (13,14).

Physical activity is defined as any bodily movement produced by skeletal muscles that results in energy expenditure beyond resting expenditure. Exercise is a subset of physical activity that is planned, structured, repetitive, and purposeful in the sense that improvement or maintenance of physical fitness is the objective. As with pharmacological therapy, for aerobic or resistance exercise therapy it is necessary to prescribe the right dose (intensity, volume, and frequency) and to carefully consider the potential side effects and contraindications. The aim of this review is to discuss a correct approach to exercise therapy and to underline the beneficial effects, precautions, and limitations of the use of exercise in type 2 diabetic subjects. Another crucial point that merits discussion is the profound gap between the exercise therapy suggested by scientific guidelines and the applicability of it in the management of type 2 diabetes. Full compliance with an exercise regimen requires high motivation and capability, both in the diabetes team operators/facilitators and in their patients, and is based on a strong therapeutic alliance. There are several obstacles in this virtuous process: lack of time and lack of confidence in the behavioral and motivation strategies of physicians and other diabetic team operators, unhealthy lifestyles of physicians who should advise exercise, and reluctance of sedentary diabetic patients to change their lifestyle, mainly due to poor self-efficacy or lack of time (15). The “no” side of this debate will discuss the evidence in the literature on the strategies that can reduce the gap and augment the clinical applicability of guidelines. In the “yes” side, we report the evidence that exercise works in the research setting and in the “no” side, that often exercise therapy fails in the primary care setting and what we should do to remedy the problem.

Discussion of the “yes” side of the debate

Several good motives, ranging from the pathophysiology of the disease to the demonstrated numerous beneficial effects for health and society, support the use of exercise as a core element in treatment of people with type 2 diabetes (114).

It is likely that most of the documented beneficial effects of exercise in type 2 diabetes are mediated by the increase of combined aerobic and resistance exercise of muscle mass and strength (5,10,16), Vo2max (2,10,16), mitochondrial biogenesis (16), and insulin sensitivity (5,17,18). In subjects with type 2 diabetes, regular aerobic, resistance, or combined exercise training results in a decline in HbA1c ranging from 0.51 to 0.73%, with a dose-dependent relationship (11). The amount of energy expenditure with exercise that produces the best dose/effect benefit ranges between 20 and 30 MET ⋅ h/week (3,10), corresponding to walking ~20–30 km/week at a speed of 4–5 km/h. However, beneficial effects can be obtained with a lesser effort, and for this reason the statements of scientific societies recommend at least 150 min/week moderate aerobic physical activity that should be combined with three weekly sessions of resistance exercise to increase muscle strength (13,14). The intensity of exercise should be in the moderate range (3–6 MET) because type 2 diabetic subjects are not familiar with high-intensity workouts and could easily drop out (15). Furthermore, moderate-intensity exercise can be sustained for a prolonged time, and training planned on moderate-intensity/long distances increases insulin sensitivity up to 14 days after the end of the last exercise session (18) and favors lipid consumption (19). However, training modalities for type 2 diabetic subjects are in constant evolution and necessitate further investigation. Very recently, continuous walking, performed at moderate intensity, has been compared with interval walking, structured in alternated 3-min repetitions at low and high intensity, in a small number of subjects with type 2 diabetes (20). Continuous walking in comparison with the control group improved glucose control, but interval walking was superior to energy expenditure–matched continuous walking for improving physical fitness, body composition, and glycemic control (20).

Regular exercise is generally recommended to maintain the beneficial effects of a weight loss (21,22), and levels of physical activity are often referred to as the best predictor of weight maintenance after significant weight loss (22,23). Interestingly, the 4-year results of the Look AHEAD (Action for Health in Diabetes) study demonstrate that the beneficial effects of the lifestyle intervention are independent of the degree of baseline obesity (12). Severely obese participants in the intensive lifestyle group had similar adherence, percentage of weight loss, and improvement in cardiovascular disease risk compared with less obese participants (12). Thus, behavioral weight loss programs, including exercise therapy, should be considered an effective option for this population (12). Recent data from the Look AHEAD study demonstrate also that in overweight adults, an intensive lifestyle intervention is associated with a greater likelihood of partial remission of type 2 diabetes compared with standard diabetes support and education (24).

The beneficial effects of exercise in type 2 diabetic subjects go well beyond improved glucose control and weight control; they also include the reduction of modifiable cardiovascular risk factors (10,12,13) and promote cardiorespiratory fitness (2,8,10,16). Several prospective studies have demonstrated a significant inverse relationship between cardiorespiratory fitness and all-cause risk of death in type 2 diabetic subjects (25,26). These studies show that an improvement of 1 MET (3.5 mL ⋅ kg−1 ⋅ min−1 oxygen uptake) reduces the risk of death by ~18% in these subjects (25,26). Higher levels of physical activity have been associated with lower mortality risk in individuals with diabetes according to prospective studies (27). However, recently the Look AHEAD Study was stopped by the National Institutes of Health because the intensive lifestyle did not decrease occurrence of cardiovascular events, which was the primary study goal (28). At the time, participants had been in the intervention for up to 11 years and the intensive lifestyle intervention has been able to achieve and maintain weight loss by decreased caloric intake and increased physical activity (28). Thus, at present there is no conclusive evidence that regular exercise can significantly reduce cardiovascular events in overweight/obese type 2 diabetic subjects. Supervised exercise therapy is recommended also to subjects with previous cardiovascular events (14). However, screening for cardiovascular disease risk prior to starting exercise is important to minimize the risk of acute exercise-induced cardiovascular complications. These aspects are discussed in detail in the joint position statement of the American Diabetes Association and the American College of Sports Medicine (14).

Regular exercise improves perceived health-related quality of life and mood status of type 2 diabetic subjects (29,30). These two beneficial effects support the World Health Organization concept that lifestyle interventions in obesity and type 2 diabetes have the potential to counteract the consequent social burden of depression (31). Patients with obesity or type 2 diabetes at the end of a multidisciplinary lifestyle intervention, in which exercise was a core element, report an improvement in their relationship with themselves and with others (32)—a distinctive result not achievable with pharmacological therapy. Strictly related to the quality of life is the circumstance that adults with type 2 diabetes often have limitations in mobility that increase with age. The recent results of the Look AHEAD study demonstrate that an intensive lifestyle intervention that produces weight loss and improves fitness could slow the loss of mobility in such patients (33).

The physician-patient relationship improves when exercise is used as a core strategy to treat type 2 diabetes because the counseling strategy to advise exercise entails empathy and listening (15,34). Directive models of diabetes care often result in noncompliance and failure to produce the desired behavior and outcomes (35). Exercise therapy, used as a core element of a multidisciplinary lifestyle intervention, considers patients as active participants in their own treatment and is a typical empowerment-based approach (36); as such, it is more appropriate for the management of chronic illnesses such as diabetes (37). To augment adhesion, exercise therapy should be individualized, considering patient preferences, and the strategy of the lifestyle motivators should be to change the patient’s perception of exercise from a sacrifice to a pleasant experience (32,34).

Given the epidemic diffusion of type 2 diabetes, more research is necessary to analyze the cost-effectiveness of exercise interventions and the optimal modalities to deliver such interventions. At present, there is promising evidence that exercise therapy can reduce the costs of the National Health Service in preventing (38) and treating type 2 diabetes (3,39). A post hoc subgroup cost analysis has estimated that the ideal financial savings are achieved when type 2 diabetic patients reach a leisure-time energy expenditure with exercise (mainly brisk walking) of 27 MET ⋅ h/week (3). It is critical to produce studies comparing the cost/utility of multidisciplinary lifestyle interventions with standard ambulatory diabetes care in clinical practice.

In conclusion, exercise can be considered a core element of type 2 diabetes therapy, characterized by several positive outcomes not entirely achievable by drug administration. However, it is challenging to convince sedentary obese individuals to change their lifestyle and to introduce exercise into a daily routine. In this regard, we need more studies reporting patients’ views on barriers and facilitators to lifestyle change (32,40), identifying the psychological profile of those who are more resistant to the change (41) and the factors associated with success of lifestyle interventions (12,23). The current literature indicates that participants in lifestyle intervention appreciated the monitoring, encouragement, and accountability provided by the staff (32,40), that motivation is increased by a multidisciplinary approach including different professionals (physicians, nurses, dietitians, exercise physiologists, and educators) (40), that walking emerged as the most frequent form of physical activity (41), and that baseline depressive mood or low levels of health-related quality of life predict low attendance at exercise sessions (41), whereas greater self-reported physical activity (23) or attendance at exercise sessions (41) was the strongest correlate of weight loss. The “no” side of this debate will further discuss these aspects on the use of exercise in the clinical setting.

Discussion of the “no” side of the debate

There is no doubt that physical activity is important for diabetes therapy, and we have very good scientific evidence that an increase in physical activity helps to improve the outcome for diabetes patients (114,24), as it is also an important strategy for diabetes prevention (38,42). On the other hand, there is no doubt that implementing this strategy in clinical practice not always leads to the expected outcomes (28,43) so that, unfortunately, physical activity strategies in praxis reach only those who are already physically active and there is no added value for the patients we have to reach: those who are physically inactive (42). Resistance training is confronted with a particularly high load of barriers, since the patient needs to have intensive training and supervision, attend a gym, and have a training plan. From this point of view, we could argue that “sports” in diabetes therapy fails to a large extent and that we need “improved” strategies to successfully increase physical activity (44).

Some of the strongest arguments for the “no” side have been presented in the introduction: “Full compliance with an exercise regimen requires high motivation and capability, both in the diabetic team operators/facilitators and in their patients, and is based on a strong therapeutic alliance.” There are additional indications of the barriers to exercise therapy. We have to build a very strong therapeutic bond and establish supervision for our patients, which is unrealistic in a medical environment where a physician sometimes has only 4 min counseling per patients and only 27 s to make a therapeutic decision (45). Furthermore, that “exercise therapy, used as a core element of a multidisciplinary lifestyle intervention, considers patients as active participants in their own treatment” also indicates why so many examples of exercise therapy in diabetic patients have failed. The physical activity intervention only works if patients become “active participants in their own treatment,” and this is only achievable with a structured behavioral support program. In conclusion, exercise therapy has often failed for the majority of diabetic patients in the primary care setting and only reaches a very tiny fraction of diabetic patients because it focuses too much on “exercise therapy” and lacks an adequate behavioral strategy as a pillar/support.

If we want to successfully increase physical activity in our patients, we can only succeed with behavioral intervention that has been adequately initiated. Exercise therapy has failed in the past because it has often been seen as a “therapy”—like taking a pill. As in most of our medication programs, it was missing adequate behavioral support and intervention strategy. Furthermore, exercise therapy, which focuses on resistance training, is the wrong way to reach the mass of our diabetic patients because the adherence to exercise among this patient group is low (1). Therefore, behavioral intervention should be instituted and focus on an increase in physical activity, which is applicable to daily life and our environment and implementable in our home lifestyle. Why isn't exercise therapy a core element for most patients with type 2 diabetes?

First, evolution has prepared us to “walk.” We are not “exercise” machines, but 10,000 years ago we had to walk probably >20,000/day for our daily survival. What is the situation today? We usually walk <5,000 steps/day (46), burn less energy, gain visceral adiposity, and accumulate chronic diseases like diabetes. Therefore, increasing the daily number of steps, supported by a group-based program, could be the most adequate intervention to increase physical activity and to improve glycemic control for all of our patients with diabetes and many other diseases (42,47,48). We can extrapolate that walking 10,000 steps/day from the age of 25 years may prevent many chronic diseases. Yates and coworkers have shown that a pragmatic structured education program that incorporates pedometer use is effective for improving glucose tolerance in subjects with impaired glucose tolerance (48). Interestingly, walking 1,000 steps more than your average per day—for a diabetic patient—reduces postprandial blood glucose by 1.6 mmol/L over a period of 2 years (48). This has the same effect on postprandial blood glucose as 1,000 mg metformin and can help to reduce the daily medication in diabetes treatment and associated therapies such as blood pressure medication or lipid-lowering drugs (49).

Second, behavior change must start at home. Behavior change affects our private life and relationships. Exercise therapy takes place in the wrong setting because you have to attend a gym as if you are going to a physician—often things you would like to avoid. On the other hand, walking steps is something that we do every day and in all situations of our life; it is already part of our daily lifestyle. Behavioral support can help us analyze the motivation to change lifestyle and to set new goals for lifestyle change. Action plans, as part of a behavioral strategy, can help patients reach goals and find ways to stimulate success and reduce relapse (50). For modification of physical activity behavior, it is much more successful to focus on the strategies that already exist in daily life than to focus on “therapeutic” strategies that take place outside the private environment. The prescription of group-based brisk walking represents an equally effective intervention to modulate glycemic control and cardiovascular risk profile in type 2 diabetic patients compared with more individualized medical fitness programs (51). Focusing on a behavioral strategy, setting new goals for the “daily step count” has a much higher chance of success of implementation in our daily life. The implementation strategy works better when education programs are based on self-management–oriented group, which supports patients to negotiate their goals and self-monitor their eating and exercise behavior and in analyzing barriers to behavior change (52). The role of health care professionals is to provide “behavioral support” and encouragement to the patients rather than treat them with specific exercise programs (42,44).

The key factor for successful diabetes care is the need to support sustained changes in lifestyle behaviors. However, achieving the required changes reliably is challenging. Both clinical weight loss programs (53,54) and real-world diabetes prevention programs vary widely in their ability to deliver weight loss or changes in physical activity. Sustained behavior change seems to be the best predictor of reliably increased effectiveness of lifestyle interventions (55). By accepting this, we can design diabetes chronic care management programs that will deliver the expected benefits and optimize cost-effectiveness in scalable, real-world disease management programs. A recent meta-analysis systematically developed evidence-based recommendations on supporting lifestyle change in people with type 2 diabetes including those with disease risk. Applying these recommendations may help guide the selection of intervention components in a way that maximizes the likely effectiveness of diabetes prevention programs (56).

Conclusions

Exercise is well known to be a potential lifestyle intervention to treat and prevent type 2 diabetes, especially when incorporated into a multidisciplinary lifestyle intervention. The evidence has been firmly established by several clinical trials. The challenge we have is to address the implementation of the evidence into clinical and public health practice—and here the question about the key items for changing lifestyle becomes relevant. Support for behavior change is the predominant issue. Physical activity is a good sign of behavior change, but maintaining physical activity requires sustained behavioral support. The more natural the behavioral strategy, the more success it will have in increasing physical activity. Walking is natural from an evolutionary point of view and may have the potential to reach the masses with the right behavioral support program and incentives. Exercise therapy is a therapy associated with a disease that can be highly successful but needs an individualized strategy, and this is only applicable for a fraction of our patients. For it to be true that “physical activity becomes a core therapeutic element for most patients with type 2 diabetes,” we have to improve our understanding of the behavioral and physiological as well as contextual mechanisms of the development of diabetes and the disease itself. To reach every patient, we need an individual proposal that can become part of daily life. Nothing is more natural than walking, and to walk our diabetes away is effectively achievable. Patients who start walking may also decide later to walk to the exercise therapy to gain even more individual benefit. Future directions for research in this field should include the comparisons by randomized controlled trials of incorporating increased physical activity into daily activity versus specific prescription of aerobic and resistance exercise.

The focus of the intervention should be on lifestyle change rather than a prescription for exercise per se. Thus, exercise support should be part of a structured lifestyle intervention and include both aerobic and resistance training. The strength of physical activity is that it addresses the mechanistic basis of type 2 diabetes. Physical activity is therefore a core element in diabetes therapy, but effective behavioral support strategies are necessary to support the achievement of physical activity goals. Only when backed by a behavioral support strategy can physical activity express its maximum potential and become a leading element for every patient with type 2 diabetes. Sometimes, the importance of structured behavioral support is treated as a justification for not embracing exercise rather than discussed as a barrier that could/should be overcome through incorporation of diabetes educators, exercise physiologists, and lay coaches into diabetes care. It has been shown that the full spectrum of psychological and clinical benefits from multidisciplinary lifestyle intervention is obtained when obese adults with or without type 2 diabetes attend both the exercise and the educational sessions (41). The multidisciplinary support is needed regardless of whether the recommendation is to engage in a structured exercise program or increase walking. The success of the behavioral intervention is strongly related to the enthusiasm and the motivation of the physicians and of the other operators of the multidisciplinary diabetes team who should not be sedentary and provide an example to their patients. It has been recently proven that physicians with a normal BMI in comparison with their overweight/obese colleagues are more likely to provide lifestyle advice (57). The Latin philosopher Lucius Annaeus Seneca (5–65 BC) wrote in one of his letters to Lucilio, “People believe more from their eyes than from their ears.”

This publication is based on the presentations from the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). The Congress and the publication of this supplement were made possible in part by unrestricted educational grants from Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Ethicon Endo-Surgery, Janssen, Medtronic, Novo Nordisk, Sanofi, and Takeda.

No potential conflicts of interest relevant to this article were reported.

P.D.F. wrote discussion of the “yes” side of the debate. P.S. wrote discussion of the “no” side of the debate. P.D.F. is the guarantor of this work and, as such, had full access to all the data and takes responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Boulé
NG
,
Haddad
E
,
Kenny
GP
,
Wells
GA
,
Sigal
RJ
.
Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials
.
JAMA
2001
;
286
:
1218
1227
[PubMed]
2.
Boulé
NG
,
Kenny
GP
,
Haddad
E
,
Wells
GA
,
Sigal
RJ
.
Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus
.
Diabetologia
2003
;
46
:
1071
1081
[PubMed]
3.
Di Loreto
C
,
Fanelli
C
,
Lucidi
P
, et al
.
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes
.
Diabetes Care
2005
;
28
:
1295
1302
[PubMed]
4.
Snowling
NJ
,
Hopkins
WG
.
Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis
.
Diabetes Care
2006
;
29
:
2518
2527
[PubMed]
5.
Thomas
DE
,
Elliott
EJ
,
Naughton
GA
.
Exercise for type 2 diabetes mellitus
.
Cochrane Database Syst Rev
2006
;
3
:
CD002968
[PubMed]
6.
Sigal
RJ
,
Kenny
GP
,
Boulé
NG
, et al
.
Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial
.
Ann Intern Med
2007
;
147
:
357
369
[PubMed]
7.
Yates
T
,
Khunti
K
,
Bull
F
,
Gorely
T
,
Davies
MJ
.
The role of physical activity in the management of impaired glucose tolerance: a systematic review
.
Diabetologia
2007
;
50
:
1116
1126
[PubMed]
8.
Hordern
MD
,
Coombes
JS
,
Cooney
LM
,
Jeffriess
L
,
Prins
JB
,
Marwick
TH
.
Effects of exercise intervention on myocardial function in type 2 diabetes
.
Heart
2009
;
95
:
1343
1349
[PubMed]
9.
Church
TS
,
Blair
SN
,
Cocreham
S
, et al
.
Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial
.
JAMA
2010
;
304
:
2253
2262
[PubMed]
10.
Balducci
S
,
Zanuso
S
,
Nicolucci
A
, et al
Italian Diabetes Exercise Study (IDES) Investigators
.
Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES)
.
Arch Intern Med
2010
;
170
:
1794
1803
[PubMed]
11.
Umpierre
D
,
Ribeiro
PA
,
Kramer
CK
, et al
.
Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis
.
JAMA
2011
;
305
:
1790
1799
[PubMed]
12.
Unick
JL
,
Beavers
D
,
Jakicic
JM
, et al
Look AHEAD Research Group
.
Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial
.
Diabetes Care
2011
;
34
:
2152
2157
[PubMed]
13.
Marwick
TH
,
Hordern
MD
,
Miller
T
, et al
Council on Clinical Cardiology, American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee
Council on Cardiovascular Disease in the Young
Council on Cardiovascular Nursing
Council on Nutrition, Physical Activity, and Metabolism
Interdisciplinary Council on Quality of Care and Outcomes Research
.
Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association
.
Circulation
2009
;
119
:
3244
3262
[PubMed]
14.
Colberg
SR
,
Albright
AL
,
Blissmer
BJ
, et al
American College of Sports Medicine
American Diabetes Association
.
Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes
.
Med Sci Sports Exerc
2010
;
42
:
2282
2303
[PubMed]
15.
Kirk
A
,
De Feo
P
.
Strategies to enhance compliance to physical activity for patients with insulin resistance
.
Appl Physiol Nutr Metab
2007
;
32
:
549
556
[PubMed]
16.
Fatone
C
,
Guescini
M
,
Balducci
S
, et al
.
Two weekly sessions of combined aerobic and resistance exercise are sufficient to provide beneficial effects in subjects with Type 2 diabetes mellitus and metabolic syndrome
.
J Endocrinol Invest
2010
;
33
:
489
495
[PubMed]
17.
De Feo
P
,
Stocchi
V
.
Physical activity for the treatment and prevention of metabolic syndrome
.
Nutr Metab Cardiovasc Dis
2007
;
17
:
327
331
18.
Bajpeyi S, Tanner CJ, Slentz CA, et al. Effect of exercise intensity and volume on the persistence of insulin sensitivity during training cessation. J Appl Physiol 2009;106:1079–1085
19.
Williams
C
.
Physiological responses to exercise
. In
Exercise and Sport in Diabetes
.
Burr
B
,
Nagi
D
, Eds.
Chichester, England
,
John Wiley & Sons
,
1999
, p.
1
24
20.
Karstoft K, Winding K, Knudsen SH, et al. The Effects of Free-Living Interval-Walking Training on Glycemic Control, Body Composition, and Physical Fitness in Type 2 Diabetes Patients: A randomized, controlled trial. Diabetes Care 2013;36:228–236
21.
Jakicic
JM
,
Clark
K
,
Coleman
E
, et al
American College of Sports Medicine
.
American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults
.
Med Sci Sports Exerc
2001
;
33
:
2145
2156
[PubMed]
22.
Klem
ML
,
Wing
RR
,
McGuire
MT
,
Seagle
HM
,
Hill
JO
.
A descriptive study of individuals successful at long-term maintenance of substantial weight loss
.
Am J Clin Nutr
1997
;
66
:
239
246
[PubMed]
23.
Wadden
TA
,
West
DS
,
Neiberg
RH
, et al
Look AHEAD Research Group
.
One-year weight losses in the Look AHEAD study: factors associated with success
.
Obesity (Silver Spring)
2009
;
17
:
713
722
[PubMed]
24.
Gregg
E
,
Chen
H
,
Wagenknecht
LE
, et al
.; Look AHEAD Research Group.
Association of an intensive lifestyle intervention with remission of type 2 diabetes
.
JAMA
2012
;
308
:
2489
2496
[PubMed]
25.
Myers
J
,
Prakash
M
,
Froelicher
V
,
Do
D
,
Partington
S
,
Atwood
JE
.
Exercise capacity and mortality among men referred for exercise testing
.
N Engl J Med
2002
;
346
:
793
801
[PubMed]
26.
Kokkinos
P
,
Myers
J
,
Nylen
E
, et al
.
Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes
.
Diabetes Care
2009
;
32
:
623
628
[PubMed]
27.
Sluik
D
,
Buijsse
B
,
Muckelbauer
R
, et al
.
Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-analysis
.
Arch Intern Med
2012
;
172
:
1
11
[PubMed]
28.
Weight loss does not lower heart disease risk from type 2 diabetes [article online],2012. Available from http://www.nih.gov/news/health/oct2012/niddk-19.htm. Accessed 21 January 2013
29.
Pedersen
BK
,
Saltin
B
.
Evidence for prescribing exercise as therapy in chronic disease
.
Scand J Med Sci Sports
2006
;
16
(
Suppl. 1
):
3
63
[PubMed]
30.
Nicolucci
A
,
Balducci
S
,
Cardelli
P
, et al
Italian Diabetes Exercise Study Investigators
.
Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES)
.
Diabetologia
2012
;
55
:
579
588
[PubMed]
31.
World Health Organization. Global strategy on diet, physical activity and health [article online]. Available from http://www.who.int/dietphysicalactivity/strategy/eb11344/strategy_english_web.pdf. Accessed 12 July 2012
32.
Piana
N
,
Battistini
D
,
Urbani
L
, et al
.
Multidisciplinary lifestyle intervention in the obese: Its impact on patients’ perception of the disease, food and physical exercise
.
Nutr Metab Cardiovasc Dis
2013
;
23
:
337
343
[PubMed]
33.
Rejeski
WJ
,
Ip
EH
,
Bertoni
AG
, et al
Look AHEAD Research Group
.
Lifestyle change and mobility in obese adults with type 2 diabetes
.
N Engl J Med
2012
;
366
:
1209
1217
[PubMed]
34.
Di Loreto
C
,
Fanelli
C
,
Lucidi
P
, et al
.
Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects
.
Diabetes Care
2003
;
26
:
404
408
[PubMed]
35.
Funnell
MM
,
Anderson
RM
.
MSJAMA: the problem with compliance in diabetes
.
JAMA
2000
;
284
:
1709
[PubMed]
36.
De Feo
P
,
Fatone
C
,
Burani
P
, et al
.
An innovative model for changing the lifestyles of persons with obesity and/or Type 2 diabetes mellitus
.
J Endocrinol Invest
2011
;
34
:
e349
e354
[PubMed]
37.
Funnell
MM
,
Anderson
RM
.
Empowerment and self-management of diabetes
.
Clin Diabetes
2004
;
22
:
123
127
38.
Diabetes Prevention Program Research Group
.
The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS
.
Diabetes Care
2012
;
35
:
723
730
[PubMed]
39.
Roine
E
,
Roine
RP
,
Räsänen
P
,
Vuori
I
,
Sintonen
H
,
Saarto
T
.
Cost-effectiveness of interventions based on physical exercise in the treatment of various diseases: a systematic literature review
.
Int J Technol Assess Health Care
2009
;
25
:
427
454
[PubMed]
40.
Casey
D
,
De Civita
M
,
Dasgupta
K
.
Understanding physical activity facilitators and barriers during and following a supervised exercise programme in Type 2 diabetes: a qualitative study
.
Diabet Med
2010
;
27
:
79
84
[PubMed]
41.
Mazzeschi
C
,
Pazzagli
C
,
Buratta
L
, et al
.
Mutual interactions between depression/quality of life and adherence to a multidisciplinary lifestyle intervention in obesity
.
J Clin Endocrinol Metab
2012
;
97
:
E2261
E2265
[PubMed]
42.
Paulweber
B
,
Valensi
P
,
Lindström
J
, et al
.
A European evidence-based guideline for the prevention of type 2 diabetes
.
Horm Metab Res
2010
;
42
(
Suppl. 1
):
S3
S36
[PubMed]
43.
Lesser
KB
,
Gruppuso
PA
,
Terry
RB
,
Carpenter
MW
.
Exercise fails to improve postprandial glycemic excursion in women with gestational diabetes
.
J Matern Fetal Med
1996
;
5
:
211
217
[PubMed]
44.
Lindström
J
,
Neumann
A
,
Sheppard
KE
, et al
.
Take action to prevent diabetes—the IMAGE toolkit for the prevention of type 2 diabetes in Europe
.
Horm Metab Res
2010
;
42
(
Suppl. 1
):
S37
S55
[PubMed]
45.
Rothe
U
,
Müller
G
,
Schwarz
PE
, et al
.
Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research
.
Diabetes Care
2008
;
31
:
863
868
[PubMed]
46.
Tudor-Locke
C
,
Bassett
DR
 Jr
.
How many steps/day are enough? Preliminary pedometer indices for public health
.
Sports Med
2004
;
34
:
1
8
[PubMed]
47.
Yates
T
,
Davies
MJ
,
Sehmi
S
,
Gorely
T
,
Khunti
K
.
The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years?
Diabet Med
2011
;
28
:
1268
1271
[PubMed]
48.
Yates
T
,
Davies
M
,
Gorely
T
,
Bull
F
,
Khunti
K
.
Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial
.
Diabetes Care
2009
;
32
:
1404
1410
[PubMed]
49.
Schwarz
PE
,
Greaves
CJ
,
Lindström
J
,
Yates
T
,
Davies
MJ
.
Nonpharmacological interventions for the prevention of type 2 diabetes mellitus
.
Nat Rev Endocrinol
2012
;
8
:
363
373
[PubMed]
50.
Greaves
CJ
,
Sheppard
KE
,
Abraham
C
, et al
IMAGE Study Group
.
Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions
.
BMC Public Health
2011
;
11
:
119
[PubMed]
51.
Praet
SF
,
van Rooij
ES
,
Wijtvliet
A
, et al
.
Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial
.
Diabetologia
2008
;
51
:
736
746
[PubMed]
52.
Kulzer
B
,
Hermanns
N
,
Reinecker
H
,
Haak
T
.
Effects of self-management training in Type 2 diabetes: a randomized, prospective trial
.
Diabet Med
2007
;
24
:
415
423
[PubMed]
53.
Avenell
A
,
Broom
J
,
Brown
TJ
, et al
.
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement
.
Health Technol Assess
2004
;
8
:
iii
iv, 1–182
[PubMed]
54.
Foster C, Hillsdon M, Thorogood M. Interventions for promoting physical activity. Cochrane Database Syst Rev 2005;CD003180
55.
Tuomilehto
J
,
Schwarz
P
,
Lindström
J
.
Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts
.
Diabetes Care
2011
;
34
(
Suppl. 2
):
S210
S214
[PubMed]
56.
Schwarz
PE
,
Albright
AL
.
Prevention of type 2 diabetes: the strategic approach for implementation
.
Horm Metab Res
2011
;
43
:
907
910
[PubMed]
57.
Bleich
SN
,
Bennett
WL
,
Gudzune
KA
,
Cooper
LA
.
Impact of physician BMI on obesity care and beliefs
.
Obesity (Silver Spring)
2012
;
20
:
999
1005
[PubMed]
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.